AUSTIN, Texas, Nov. 9, 2011 /PRNewswire/ -- Inova Labs, Inc., a medical device development company, today announced the launch of the LifeChoice® portable oxygen concentrator (POC) with Auto Mode technology.
(Logo: http://photos.prnewswire.com/prnh/20111109/DA03505LOGO)
Weighing only 4.9 pounds, the LifeChoice POC with Auto Mode technology is the first portable oxygen concentrator to automatically detect and adjust patient therapy based on oxygen requirements for periods of activity and sleep. Now patients treated with supplemental oxygen therapy can stay active and sleep well—anytime, anywhere.
During the Active mode, the LifeChoice POC will automatically detect and provide oxygen to support a higher respiration rate. During the Sleep mode, it will automatically adjust the trigger of oxygen delivery to be 10 times more sensitive to detect shallow breathing during rest.
The LifeChoice POC delivers true mobility and independence without tanks and carts. The novel technology can be used as both a portable and stationary oxygen concentrator, providing around-the-clock therapy. The device has a treatment range for prescription oxygen users between 1 to 3 liters per minute oxygen equivalent.
Reimbursed by Medicare and most private insurance plans, the LifeChoice POC is the only technology that features the pulse-wave delivery system to provide oxygen "on demand" congruent with a patient's normal breathing pattern. In addition, side effects from retrograde flow, such as nasal irritation and nosebleeds, are minimized with the pulse-wave delivery system.
For more information about the LifeChoice POC, visit http://www.lifechoiceoxygen.com or call the customer care center at 1-800-220-0977.
About Inova Labs
Inova Labs is an Austin, Texas-based medical device company that develops and commercializes innovative products for the COPD market. The company is currently marketing the LifeChoice® Portable Oxygen Concentrator System, which is the lightest and smallest oxygen concentrator on the market with FDA approval for continuous use by patients. LifeChoice® delivers oxygen to the COPD patient using a proprietary "Pulse Wave" technology, which ensures that the patient receives maximum benefit from the oxygen produced. LifeChoice® also offers "Auto Mode" technology, enabling the patient to automatically receive the prescribed oxygen dose during periods of activity, as well as sleep. The product is approved by the FAA for air travel and is manufactured under strict ISO certification guidelines.
Contact: Lindsey Gehrig or Meredith Michelson
(512) 472-9599
[email protected] or [email protected]
SOURCE Inova Labs
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article